Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer

RESEARCH TRIANGLE PARK, N.C., June 12, 2025 /PRNewswire/ — Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly and neurologically impaired individuals, today announced that Jeff Welch has been named as Chief Operating Officer.

Mr. Welch comes to Dignify with over two decades of diverse business experience as a successful entrepreneur and business executive from startup to acquisition. He has worked as a senior executive in clinical trials for pharmaceutical, biotechnology, and med-tech companies seeking to develop their assets into safe and effective treatment options. His experience includes multiple leadership roles in business development, branding, marketing, corporate communications, and strategic planning activities.

We are thrilled to welcome Jeff to our executive team,” said Anthony DiTonno, CEO of Dignify. His skills and experience align well with Dignify’s business priorities. As we enter a pivotal phase of growth, Jeff has a wide appreciation of the complexities associated with getting a drug or device to market. From fundraising and building a team of KOLs to navigating the regulatory landscape, he will be instrumental in executing our mission to bring Dignify’s treatments to patients.

About Dignify Therapeutics

Founded by a team of serial entrepreneurs who are internationally recognized scientists, Dignify Therapeutics’ mission is to provide practical and convenient treatments for bladder and bowel voiding dysfunctions, primarily using a repositioning strategy of drug discovery that the team has successfully implemented multiple times over the last 20 years in the fields of urology and gastroenterology.

The Company is funded by founders, venture capital firms (RA Capital Management and Eshelman Ventures), the North Carolina Biotechnology Center, the One NC Small Business Program, and the NIH SBIR/STTR program (with 18 awards and approximately $18 million in funding). Dignify Therapeutics is located in the First Flight Venture Center in Research Triangle Park, North Carolina.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dignify-therapeutics-announces-jeff-welch-as-chief-operating-officer-302480520.html

SOURCE Dignify Therapeutics

Staff

Recent Posts

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

2 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

2 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

2 hours ago

Calm Nature CBD Gummies Ingredients: 2026 Consumer Analysis Examines Full Spectrum CBD Claims, Testing Standards, and Formulation Transparency

Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal…

2 hours ago